SLF TFA

Target: This ligand targets FK506-binding protein FKBP12 in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for FK506-binding protein FKBP12. In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings FK506-binding protein FKBP12 into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• PROTAC Ligand for E3 Recruitment: SLF TFA can be used as a small-molecule targeting ligand component in PROTAC designs to engage an E3 ubiquitin ligase through a ternary complex. This enables systematic exploration of degrader potency, including how linker length and attachment geometry influence ubiquitination efficiency and subsequent target protein degradation.

• Ternary Complex Optimization: In PROTAC workflows, SLF TFA serves as a modular moiety to tune binding cooperativity between the target protein ligand and the E3 ligase. Researchers can evaluate ternary complex formation by biochemical assays and correlate complex stability with degradation kinetics, helping identify conditions that maximize target engagement while minimizing off-target ubiquitination.

• Targeted Degradation Assay Development: SLF TFA-based PROTAC constructs can be applied to establish robust degradation assays, including time-course and dose-response studies in relevant cell models. By quantifying target loss via immunoblotting or proteomics, investigators can determine degradation selectivity, calculate DC50 values, and compare degradation versus inhibition profiles.

• Mechanism-of-Action Studies: SLF TFA-enabled PROTACs are suited for mechanistic interrogation of the ubiquitin-proteasome pathway. Experiments such as proteasome inhibition, ubiquitination dependency testing, and competition with pathway ligands can confirm that observed protein reduction arises from targeted ubiquitination and proteasomal turnover rather than transcriptional or translational effects.

SLF TFA is a FKBP-family ligand intended for use as the target-engaging component or reference ligand in PROTAC discovery workflows. Its known small-molecule recognition profile enables rational linker-vector evaluation and comparative degrader design. This molecule is described in detail below.

Structure: The structure of SLF TFA is characterized by carboxylic acid or carboxylate handle; primary or secondary amine/basic nitrogen centers; halogenated aryl/heteroaryl ring system; macrocyclic or peptidomimetic scaffold. These features provide defined hydrogen-bonding, hydrophobic, and steric elements that can support affinity retention while enabling analogue-based linker-vector selection.

Reactivity: The acid handle supports amide coupling with amino-PEG, alkyl-diamine, piperazine, or aminoalkyl E3-ligase ligands. For FKBP-directed chemical biology, it may be connected to degradation or dimerization modules through flexible PEG/alkyl or amide-containing linkers, subject to FKBP-binding SAR. In practice, incorporation into PROTACs should begin from derivatives that preserve the reported binding pharmacophore, followed by systematic variation of linker length, polarity, rigidity, and exit-vector geometry to optimize target engagement, E3 recruitment, and cellular degradation readouts.